Nova Eye Medical has established the iTrack Global Data Registry, which will collect prospective data on canaloplasty in the treatment of glaucoma, according to a press release.
The registry is a collaboration with the International Glaucoma Surgery Registry and will document real-world clinical evidence on the iTrack and iTrack Advance across North America, Europe and the Asia Pacific region.
“The iTrack Global Data Registry is providing high-quality, real-world evidence of the effectiveness and safety of canaloplasty to treat glaucoma and ocular hypertension,” Nathan Kerr, BHB,